InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.05
(
-0.21%
)
US TECH 100
19,671.20
(
-0.16%
)
Dow Jones
42,454.12
(
-0.14%
)
Brent Oil
78.70
(
-0.46%
)
Bitcoin
61,011.41
(
1.23%
)
Post# of 353189
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

raspi

Send PM Follow Ignore
Followers 0
Posts 15
Boards Moderated 0
Alias Born 05/11/2006

raspi

Re: None

Thursday, 03/01/2007 5:14:27 PM

Thursday, March 01, 2007 5:14:27 PM

Post# of 353189
NEOL could be HOT!!!
Explanation for recent rise!
While reading the latest issue of Journal of Clinical Oncology (most prestigious oncology journal) published today, I stumbled upon a report describing the effect of Cintredekin Besudotox (IL13-PE38QQR) on Recurrent Malignant Glioma published by UCSF group. This happens to be the drug being developed by NEOL. They conclude that Cintredekin appears to have a favorable effect on patients with relapsed glioblastoma..
http://www.jco.org/cgi/content/abstract/25/7/837
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up